Literature DB >> 8238382

Transforming growth factor-beta is a renin secretagogue at picomolar concentrations.

I Antonipillai1, T H Le, L Soceneantu, R Horton.   

Abstract

Transforming growth factor-beta s (TGF-beta s), a family of peptides, have many actions including modulating cellular growth, differentiation, and influencing steroidogenesis. Because both TGF-beta and renin are present in renal juxtaglomerular cells, we have examined the effects of these peptides on renin secretion using static incubations of rat renal cortical slices. We report here an effect of both TGF-beta 1 and -beta 2 on renin secretion. At low concentrations, both TGF-beta 1 (4 x 10(-12) M) and -beta 2 (8 x 10(-12) M) stimulate basal renin secretion (control, 100 +/- 4%; TGF-beta 1, 123 +/- 4%; TGF-beta 2, 124 +/- 5%; both P < 0.02 compared with control). However, at higher concentrations (2 x 10(-10) M), both peptides do not alter basal renin release. Our previous studies show that both prostaglandins and lipoxygenase (LO) products of arachidonic acid play an important dual regulatory role in renin secretion; therefore, we have examined the effects of both cyclooxygenase (CO) and LO inhibition in TGF-beta action.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238382     DOI: 10.1152/ajprenal.1993.265.4.F537

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  [Paraneoplastic syndrome in renal cell carcinoma].

Authors:  J Bedke; S Buse; M Kurosch; A Haferkamp; D Jäger; M Hohenfellner
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

2.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

Authors:  D E Clouthier; S A Comerford; R E Hammer
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 3.  Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.

Authors:  P August; B Leventhal; M Suthanthiran
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 4.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

5.  Aortic PWV in chronic kidney disease: a CRIC ancillary study.

Authors:  Raymond R Townsend; Neil J Wimmer; Julio A Chirinos; Afshin Parsa; Matthew Weir; Kalyani Perumal; James P Lash; Jing Chen; Susan P Steigerwalt; John Flack; Alan S Go; Mohammed Rafey; Mahboob Rahman; Angela Sheridan; Crystal A Gadegbeku; Nancy A Robinson; Marshall Joffe
Journal:  Am J Hypertens       Date:  2009-12-17       Impact factor: 2.689

6.  Transforming growth factor beta and excess burden of renal disease.

Authors:  Phyllis August; Vijay Sharma; Ruchuang Ding; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

7.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

8.  Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans.

Authors:  Manikkam Suthanthiran; Linda M Gerber; Joseph E Schwartz; Vijay K Sharma; Mara Medeiros; Rosemerie Marion; Thomas G Pickering; Phyllis August
Journal:  Kidney Int       Date:  2009-03-11       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.